Results 11 to 20 of about 3,293,378 (262)

153 Do Hydroxychloroquine, Disease-Modifying Antirheumatic Agents or Steroids, Serve to Prevent COVID-19 Infection? [PDF]

Ann Emerg Med, 2020
Daniel C. Keyes, A. Haidous, C R Lake, K. Stipek, Lucy Holmes McHugh   +4 more
openalex   +2 more sources

Evaluation of impaired growth plate development of long bones in skeletally immature mice by antirheumatic agents [PDF]

J Orthop Res, 2020
Marjolein M. J. Caron, Bert van Rietbergen, Tessy M. R. Castermans, Mirella J.J. Haartmans, Lodewijk W. van Rhijn, Tim J. M. Welting, Adhiambo M. Witlox   +6 more
openalex   +2 more sources

2. Antirheumatic Agents, 1) Non-biologic Agents

Nihon Naika Gakkai Zasshi, 2012
Naoto Tamura
openaire   +3 more sources

Effects of Abatacept in patients with rheumatoid arthritis and cancer risk [PDF]

Reviews in Clinical Medicine, 2023
Introduction: As a chronic autoimmune disease, Rheumatoid arthritis (RA) affects the joints. Studies have shown a complex and challenging link between cancer and RA.
Saba Homapoor, Maryam Sahebari, Mandana Khodashahi   +2 more
doaj   +1 more source

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims The aim of this study was to investigate long-term post-discontinuation outcomes in patients with rheumatoid arthritis (RA) who had been treated with tumor necrosis factor-α inhibitors (TNF-αi) which was then discontinued.
Kichul Shin, Hyun Mi Kwon, Min Jung Kim, Myung Jae Yoon, Hyun Gyung Chai, Seong-Wook Kang, Won Park, Sung-Hwan Park, Chang Hee Suh, Hyun Ah Kim, Seung-Geun Lee, Choong Ki Lee, Sang-Cheol Bae, Yong-Beom Park, Yeong Wook Song   +14 more
doaj   +1 more source

Antirheumatic Agents. I. Novel Methotrexate Derivatives Bearing an Indoline Moiety.

Chemical and pharmaceutical bulletin, 1996
Hiroharu Matsuoka, Nobuaki Kato, K. TSUJI, Noriaki Maruyama, Hiroshi Suzuki, Masahiko Mihara, Yasuhisa Takeda, Keiichi Yano   +7 more
openalex   +3 more sources

Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials

Arthritis Research & Therapy, 2023
Background This study sought to evaluate the efficacy and safety of tofacitinib in patients with rheumatoid arthritis with distinct treatment histories. Methods Pooled phase II/III trial data from patients who received tofacitinib 5 or 10 mg twice daily ...
John Tesser, Ahmet Gül, Ewa Olech, Kurt Oelke, Tatjana Lukic, Kenneth Kwok, Abbas Ebrahim   +6 more
doaj   +1 more source

Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims The objective of this study was to compare changes in the simplified disease activity index (SDAI) between biologic (b) and conventional (c) disease-modifying antirheumatic drugs (DMARD) users with seropositive rheumatoid arthritis (RA ...
Kichul Shin, Sung Soo Kim, Sang-Heon Lee, Seung-Jae Hong, Sung Jae Choi, Jung-Yoon Choe, Seung-Geun Lee, Hoon-Suk Cha, Eun Young Lee, Sung-Hwan Park, Jin-Wuk Hur, Sung Soo Na, Chang-Hee Suh, Min Wook So, Seung Won Choi, Dong-Hyuk Sheen, Won Park, Shin-Seok Lee, Wan Hee Ryu, Jin Seok Kim, Jung Soo Song, Hye Soon Lee, Seong Ho Kim, Dae-Hyun Yoo   +23 more
doaj   +1 more source

Patients With Rheumatoid Arthritis With an Inadequate Response to Disease‐Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Cardiovascular disease is the most common cause of death in patients with rheumatoid arthritis. It is believed that using disease‐modifying antirheumatic drugs (DMARDs) to control inflammation can reduce the risk of cardiovascular disease.
Chung‐Yuan Hsu, Yu‐Jih Su, Jia‐Feng Chen, Chi‐Chin Sun, Tien‐Tsai Cheng, Tzu‐Hsien Tsai, Shang‐Hong Lin, Cheng‐Chieh Chang, Tien‐Hsing Chen   +8 more
doaj   +1 more source

Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review

Frontiers in Medicine, 2022
BackgroundCOVID-19 may present different degrees of severity. Viral infections in patients with rheumatic inflammatory diseases (R-IMID) trend to present more severe disease.
David Martínez-López, Ivan Ferraz-Amaro, Diana Prieto-Peña, Lara Sánchez-Bilbao, Alba Herrero-Morant, Carmen Álvarez-Reguera, Fabricio Benavides-Villanueva, Cristina Corrales-Selaya, Martín Trigueros-Vázquez, Miguel Ángel González-Gay, Ricardo Blanco   +10 more
doaj   +1 more source